AB
Alpenglow Biosciences, Inc.
SEC filingOther Health Care · Seattle, WA
Amount raised$3Msold at filing
Total offering$3M
Investors in the raise14count reported to the SEC
FiledDec 31, 2025first sale Mar 7, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Daniella T.C. KranjacDirector
Jonathan T.C. LiuDirector
Nicholas P. RederExecutive Officer, Director
Michael T.C. DuttonExecutive Officer
Executive officers, directors and promoters as listed on the Form D.